Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

GPs do not have to do rectal exams when trying to diagnose prostate cancer as it is a ‘poor test', leading urologists have ...

A new genetic study on the causes of chronic kidney disease that combined multiple health measurements has led to a more ...

A team led by the University of Sydney has identified red blood cell rupture at dying endothelial sites as a primary driver ...

Otsuka's experimental therapy for a potentially life-threatening kidney disease more than halved severe levels of protein in the urine of patients, intensifying the battle for an effective new ...

Hypertension, a global health crisis affecting over a billion adults, significantly elevates the risk of stroke, aneurysm, ...

The gut microbiome is essential for human health and disease, acting in a symbiotic relationship with its host. In chronic ...

The renal function test market will expand significantly during the upcoming ten years due to anticipated growth of diagnostic tests designed for kidney function evaluation. Market analysts forecast ...

A recent study reveals that blood type incompatibility is a significant barrier for kidney transplants in India, with 87% of ...

*Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan. Tel: +81-22-795-6831. Fax: +81-22 ...

FILSPARI holds strong market potential as the first FDA-approved non-immunosuppressive therapy for IgA nephropathy, a rare kidney disease with significant unmet needs. As more patients and providers ...

DelveInsight's "FILSPARI Market Size, Forecast, and Market Insight Report" highlights the details around FILSPARI, the first ...